Stock News
Categories
- All
 - Editor's Picks
 - Stock Analysis
 - Stock Market News
 - Q&A with Gurus
 - Gurus' Stock Picks
 - Insider Transaction
 - Earning Reports
 - Press Release
 - Crypto Press Release
 - Earnings Call Transcripts
 - Instant Alerts
 
 Industries 
 - Aerospace & Defense
 - Agriculture
 - Asset Management
 - Banks
 - Beverages - Alcoholic
 - Beverages - Non-Alcoholic
 - Biotechnology
 - Building Materials
 - Business Services
 - Capital Markets
 - Chemicals
 - Conglomerates
 - Construction
 - Consumer Packaged Goods
 - Credit Services
 - Diversified Financial Services
 - Drug Manufacturers
 - Education
 - Farm & Heavy Construction Machinery
 - Forest Products
 - Furnishings, Fixtures & Appliances
 - Hardware
 - Healthcare Plans
 - Healthcare Providers & Services
 - Homebuilding & Construction
 - Industrial Distribution
 - Industrial Products
 - Insurance
 - Interactive Media
 - Manufacturing - Apparel & Accessories
 - Media - Diversified
 - Medical Devices & Instruments
 - Medical Diagnostics & Research
 - Medical Distribution
 - Metals & Mining
 - Oil & Gas
 - Other Energy Sources
 - Packaging & Containers
 - Personal Services
 - Real Estate
 - REITs
 - Restaurants
 - Retail - Cyclical
 - Retail - Defensive
 - Semiconductors
 - Software
 - Steel
 - Telecommunication Services
 - Tobacco Products
 - Transportation
 - Travel & Leisure
 - Utilities - Independent Power Producers
 - Utilities - Regulated
 - Vehicles & Parts
 - Waste Management
 
  Software    
 CrowdStrike Holdings Inc (CRWD) Q2 2026 Earnings Call Highlights: Record Growth and Strategic Acquisitions Propel Performance
CrowdStrike Holdings Inc (CRWD) reports impressive Q2 results with record ARR and free cash flow, while strategic moves like the Onum acquisition aim to enhance its competitive edge. Aug 28, 2025    
  Medical Diagnostics & Research    
 Agilent Technologies Inc (A) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance
Agilent Technologies Inc (A) surpasses revenue expectations and raises full-year guidance, driven by robust performance in pharma and chemicals sectors. Aug 28, 2025    

















